Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Solid Tumor, Adult|Metastatic Nonsmall Cell Lung Cancer|Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Cervical Carcinoma|Metastatic Ovarian Carcinoma|Malignant Uterine Neoplasm|Vulvar Cancer|Invasive Breast Cancer|Metastatic Breast Carcinoma|Prognostic Stage IV Breast Cancer AJCC v8|Recurrent Breast Carcinoma|Recurrent Cervical Carcinoma|Recurrent Lung Non-Small Cell Carcinoma|Recurrent Ovarian Carcinoma|Recurrent Vulvar Carcinoma|Stage IV Cervical Cancer AJCC v8|Stage IV Lung Cancer AJCC v8|Stage IV Vulvar Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IVA Cervical Cancer AJCC v8|Stage IVA Lung Cancer AJCC v8|Stage IVA Ovarian Cancer AJCC v8|Stage IVA Vulvar Cancer AJCC v8|Stage IVB Cervical Cancer AJCC v8|Stage IVB Lung Cancer AJCC v8|Stage IVB Ovarian Cancer AJCC v8|Stage IVB Vulvar Cancer AJCC v8|Vulva Squamous Cell Carcinoma
Interventions: OTHER: Blood draws|OTHER: QLQ-CIPN20 Survey|OTHER: PR-CTCAE Survey
Sponsor: Wake Forest University Health Sciences
Collaborators: National Cancer Institute (NCI)